Azurity Pharmaceuticals
azurity.com
As featured in
View 2 jobs
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Jobs
Financials
Overview
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company's patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients.
News
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
Woburn, MA, July 21, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, a privately held specialty pharmaceutical company, today announced plans ...
Read more
Report
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid Woburn, MA-July 21, 2026-Azurity Pharmaceuticals, a privately held specialty pharmaceutical company, today announced plans to commercializ
Read more
Report
Azurity Pharmaceuticals Expands Portfolio with CONTRAVE and Related Assets
WOBURN, Mass. - June 30, 2026 - Azurity Pharmaceuticals, a global pharmaceutical company dedicated to redefining medicine for the real world, today announced the expansion of its portfolio through the acquisition of CONTRAVE and related assets, expanding
Read more
Report
Azurity Pharmaceuticals Announces FDA Approval of Aprepitant Injectable Emulsion, Expanding Access to Critical Supportive Oncology Care
Azurity Pharmaceuticals Announces FDA Approval of Aprepitant Injectable Emulsion, Expanding Access to Critical Supportive Oncology Care Ready-to-use formulation to help treatment preparation without the use of polysorbate-80 WOBURN, MA - June 25, 2026 - A
Read more
Report
ACA Pharma and Azurity Pharmaceuticals Announce Approval of Feraheme and Ferabright in Macau
ACA Pharma and Azurity Pharmaceuticals Announce Approval of Feraheme and Ferabright in Macau NEW YORK, NY May 21, 2026 - ACA Pharma and Azurity Pharmaceuticals announced that Feraheme and Ferabright have each received regulatory approval in Macau, marking
Read more
Report
Pro access
Upgrade to see all 18 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Technologies
Tech DNA
Claude
LLM
AI/ML
Claude
Claude Code
LLM
Other
GDPR
Power BI
Tableau
Stack modernity
84/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
In-demand technologies
GDPR
2 jobs
Required
Tableau
1 job
Required
Claude
1 job
Required
Claude Code
1 job
Required
Power BI
1 job
Required
LLM
1 job
Required
Salary medians are calculated from this company's open jobs and compared with the market.
Industry adoption
LLM
13%
Claude
10%
Claude Code
6%
Tableau
5%
Power BI
5%
GDPR
4%
Share of companies in the same industry that use each technology.
Stack changes
Tableau
Aug 2026
Power BI
Aug 2026
LLM
Aug 2026
Claude Code
Aug 2026
Claude
Aug 2026
GDPR
Aug 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.
Roche Poland
Akamai
Airbnb
Snowflake
Harvey
Showpad
Growth
Hiring Momentum
83/100
Scaling fast
Open positions
2
1 opened / 1 closed in 30 days
ATS activity
Every ~10 hours
08/31/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Executive
50% ▲
Analytics
50% ▲
Activity Timeline
Added Tableau to stack
Aug 2026
Added Power BI to stack
Aug 2026
Added LLM to stack
Aug 2026
Added Claude Code to stack
Aug 2026
Added Claude to stack
Aug 2026
Added GDPR to stack
Aug 2026
Jobs
≈ $153k – $291k per year (Estimated) • Remote/Hybrid • Bachelor's Degree • Raleigh
GDPR
Apply
≈ $130k – $280k per year (Estimated) • Remote/Hybrid • Contractor • 10+ years exp • Bachelor's Degree
Claude
Claude Code
LLM
Cybersecurity
GDPR
Analytics
Power BI
Tableau
Apply